Cargando…
Betulin-Based Oleogel to Improve Wound Healing in Dystrophic Epidermolysis Bullosa: A Prospective Controlled Proof-of-Concept Study
INTRODUCTION: Skin fragility and recurrent wounds are hallmarks of hereditary epidermolysis bullosa (EB). Treatment options to accelerate wound healing are urgently needed. Oleogel-S10 contains a betulin-rich triterpene extract from birch bark. In this study, we tested the wound healing properties o...
Autores principales: | Schwieger-Briel, Agnes, Kiritsi, Dimitra, Schempp, Christoph, Has, Cristina, Schumann, Hauke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458380/ https://www.ncbi.nlm.nih.gov/pubmed/28611842 http://dx.doi.org/10.1155/2017/5068969 |
Ejemplares similares
-
Mechanism of Oleogel‐S10: A triterpene preparation for the treatment of epidermolysis bullosa
por: Schwieger‐Briel, Agnes, et al.
Publicado: (2019) -
EGFR inhibition for metastasized cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa
por: Diociaiuti, Andrea, et al.
Publicado: (2019) -
Oleogel-S10 Phase 3 study “EASE” for epidermolysis bullosa: study design and rationale
por: Kern, Johannes S., et al.
Publicado: (2019) -
Dystrophic Epidermolysis Bullosa: Secondary Disease Mechanisms and Disease Modifiers
por: Nyström, Alexander, et al.
Publicado: (2021) -
Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms
por: Nyström, Alexander, et al.
Publicado: (2015)